Jacob E. Gillis

950 citations
13 papers · 638 · 1 hit paper · h-index 9

Impact in

  • Immunology top 10%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 2
    • IL-33, ST2, and ILC Pathways 2
    • CRISPR and Genetic Engineering 2

Jacob E. Gillis

11 papers receiving 631 citations

Jacob E. Gillis's Hit Papers

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance 2023 · 131 citations
1310+1+2Years since publication4080120

Peers

Jacob E. Gillis
Comparison fields: 5 of 65
  • Immunology 225
  • Oncology 254
  • Cancer Research 104
  • Pulmonary and Respiratory Medicine 147
  • Biological Psychiatry 11
Replace Sofia M. Shea with:
Sofia M. Shea United States
Felipe Gálvez‐Cancino Chile
Nicoletta Caronni Italy
Tabea Moll United States
Hiromu Yano Japan
Tomasz Adamus United States
Shane Foo United Kingdom
Zhendong Chen China
Kelly Foley United States
Davide Mangani United States
Jacob E. Gillis relative to Sofia M. Shea United States Sofia M. Shea's profile →
Citations per field
00.5×
Sofia M. Shea · 1×
Citations per year

Countries citing papers authored by Jacob E. Gillis

Since Specialization
Citations

This map shows the geographic impact of Jacob E. Gillis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Gillis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Gillis more than expected).

Fields of papers citing papers by Jacob E. Gillis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob E. Gillis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Gillis. The network helps show where Jacob E. Gillis may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacob E. Gillis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacob E. Gillis Line = papers co-authored together Jacob E. Gillis links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 2019174
2 2020145
3
Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
Hit paper breakdown →
2023131
4 201984
5 202430
6 202322
7 201817
8 202517
9 202310
10 20204
11 20234
12 20250
13 20240

About Jacob E. Gillis

Jacob E. Gillis is a scholar working on Immunology, Molecular Biology, Oncology, Physiology and Surgery, having authored 13 papers that have together received 638 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Asthma and respiratory diseases (3 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), IL-33, ST2, and ILC Pathways (2 papers), CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Diabetes Management and Research (1 paper). The work is most often cited by research in Immunology (225 citations), Oncology (254 citations), Cancer Research (104 citations), Pulmonary and Respiratory Medicine (147 citations) and Biological Psychiatry (11 citations). Jacob E. Gillis has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Arlene H. Sharpe, Martin W. LaFleur, Thao H. Nguyen, Emily F. Gaudiano, Gordon J. Freeman, W. Nicholas Haining, Kathleen B. Yates, Justin D. Trombley, Brian C. Miller and Rose Al Abosy. Their work appears in journals such as Nature Immunology, Nature Communications, Cytokine, Nature and Journal of Diabetes Science and Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact